Two years ago, it was discovered that I have the JAK2 mutation, that is part of my cancer. People have asked me what it is, and what it means, in regards to my cancer. This was the easiest explanation, I was able to find:
What is JAK2 and what does it do in our bodies?
The story of JAK2 and MPDs begins inside our bone marrow. The long bones in our body contain a spongy tissue called bone marrow. Inside the bone marrow are special “progenitor” cells or stem cells, which can grow into any of the three types of blood cells in our bodies: red blood cells, platelets, and white blood cells.
If we looked inside the stem cells, we would find different types of molecules that form a communications pathway for messages traveling inside the cell. One of these molecules is an enzyme called JAK2.
When our bodies want to make more red blood cells, for instance, we send a hormone called erythropoietin (or EPO) out into our bloodstream. The EPO hormone travels through the bloodstream and eventually reaches the bone marrow, where it finds the stem cells. The hormone then locks onto a receptor site on the surface of the stem cell, which then in turn locks onto the JAK2 molecule inside the cell. This changes the structure of the JAK2 molecule, so that the JAK2 can transmit the message forward to other proteins on the communications pathway. The message tells the cell nucleus to grow and produce more red blood cells.
Many patients with MPDs develop a mutation in the JAK2 enzyme. The mutation changes the way the JAK2 operates. The JAK2 doesn't simply transmit a signal in response to the EPO hormone, but instead acts on its own, amplifying the signal from the receptor. The excessively strong signal causes the body to produce too many blood cells.
The story of JAK2 and MPDs begins inside our bone marrow. The long bones in our body contain a spongy tissue called bone marrow. Inside the bone marrow are special “progenitor” cells or stem cells, which can grow into any of the three types of blood cells in our bodies: red blood cells, platelets, and white blood cells.
If we looked inside the stem cells, we would find different types of molecules that form a communications pathway for messages traveling inside the cell. One of these molecules is an enzyme called JAK2.
When our bodies want to make more red blood cells, for instance, we send a hormone called erythropoietin (or EPO) out into our bloodstream. The EPO hormone travels through the bloodstream and eventually reaches the bone marrow, where it finds the stem cells. The hormone then locks onto a receptor site on the surface of the stem cell, which then in turn locks onto the JAK2 molecule inside the cell. This changes the structure of the JAK2 molecule, so that the JAK2 can transmit the message forward to other proteins on the communications pathway. The message tells the cell nucleus to grow and produce more red blood cells.
Many patients with MPDs develop a mutation in the JAK2 enzyme. The mutation changes the way the JAK2 operates. The JAK2 doesn't simply transmit a signal in response to the EPO hormone, but instead acts on its own, amplifying the signal from the receptor. The excessively strong signal causes the body to produce too many blood cells.

0 comments:
Post a Comment